The Saint Louis University Institute for Drug and Biotherapeutic Innovation (SLU-IDBI) is a multidisciplinary association of researchers with a shared interest in drug and biotherapeutic discovery and development.


As primary drug discovery and development has moved from big pharma back into academia, SLU-IDBI members have skills that range the full spectrum of what is needed for drug discovery and development, including target identification and validation, primary drug screening, medicinal chemistry optimization of screening hits, pharmacological characterization and optimization of promising compounds, and clinical trials for novel therapeutics. We are interested in partnering with like-minded researchers in academia and industry.

Stay Up To Date